Loading asset research
SciSparc Ltd. Ordinary Shares
SPRCNasdaq · USD · StocksQuote as of · Exchange session not verified$4.45
-4.91%
Today
SPRC
Loading 1D prices…
Market cap
$2.7M
Volume
23.9K
52w high
$80.1052w low
$2.98Company profile
SciSparc Ltd. Ordinary Shares
SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. The company sells hemp seed oil-based products and others. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and palmitoylethanolamide oral tablets CannAmide in softgel capsule form. It also has an agreement with The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation; and a collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
TEL AVIV, Israel, United States
Employees
3
Fiscal year end
1231
CIK
1611746
Session & valuation
Open$5.19
Previous close$4.68
Day high$5.19
Day low$4.39
30-day avg. volume56.4K
Outstanding shares365.4K
Diluted EPS$203.89
Latest annual period
P/E (trailing)0.05
P/E (forward)—
Price / book0.40
Beta2.44
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| APUSApimeds Pharmaceuticals US Inc. Common Stock | $2.6M | $0.00 | — | -$0.55 | +4.37% | Unrated |
| CDTCDT Equity Inc. Common Stock | $2.6M | $0.00 | — | -$1,177.89 | -4.04% | Unrated |
| GNPXGenprex Inc. Common Stock | $2.7M | $0.00 | — | -$382.80 | +1.47% | Unrated |
| ONCOOnconetix Inc. Common Stock | $2.9M | $815.4K | -1720.98% | -$16.56 | +0.15% | Unrated |
| PPBTPurple Biotech Ltd. American Depositary Shares | $2.5M | $0.00 | — | -$54.00 | +0.98% | Buy |